NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis

INTRODUCTION: The absence of a reliable, universal biomarker is a significant limitation in neuroendocrine neoplasia (NEN) management. We prospectively evaluated two CgA assays, (NEOLISA, EuroDiagnostica) and (CgA ELISA, Demeditec Diagnostics (DD)) and compared the results to the NETest. METHODS: NE...

Descripción completa

Detalles Bibliográficos
Autores principales: Malczewska, Anna, Oberg, Kjell, Kos-Kudla, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923057/
https://www.ncbi.nlm.nih.gov/pubmed/33289691
http://dx.doi.org/10.1530/EC-20-0417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923057/
https://www.ncbi.nlm.nih.gov/pubmed/33289691
http://dx.doi.org/10.1530/EC-20-0417

Ejemplares similares